This is a preview of subscription content, log in via an institution to check access.
Notes
the proportion of patients reaching the minimum treatment duration of 3 years
Reference
Kiel MA, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. Journal of Allergy and Clinical Immunology : 4 May 2013. Available from: URL: http://dx.doi.org/10.1016/j.jaci.2013.03.013
Rights and permissions
About this article
Cite this article
"Strikingly low" compliance with allergen immunotherapy is costly. PharmacoEcon Outcomes News 679, 4 (2013). https://doi.org/10.1007/s40274-013-0426-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0426-2